Reason for request
Renouvellement d'inscription
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
eNq1mF1v2jAUhu/5FVHuScJHC5sC1cbaDanVGC3atBtkkpNiltrpsQPpfv0cQjeYHLWY+jK2854Tn9ePjxJeFA+pswYUlLOB2/IC1wEW8Ziy+4E7u7tq9t2LYSNckTXZW9bzAq/Vdp0oJUIM3HLWWwBhwvtxc/0J1PuA7rDhhHyxgkgerMslTb0vRCxvSFauccI1p7HzAHLJ44Gb5XI76oRCospiuOH4S2QkgtDfjezPrubd/fHQL8VeoZoLwGvC7rWiwIw0oxwRmBwRCfccn7TSSTRv93vnQdA3CkHFFATPMYIJkcsJ8jWNIdZHIqkAoyDJJr4FXKcgyyBacX8VPQgjcbIixRQex/qkP6jZkSxkM2i2er2zTtDtdNu9XmAUCve2Sm8e9RF+NG91Ou2g3/GB+dGSLpAXlEGTcUxSXpBIPRjWasJRktRSlagYHfrNUhyExxfdEFORpeTJW4nMdKsIEjUNqKhg70PKL7hDxalU7dl/+ixPU//IrGc7iljKuITUiOdM1sDkamq6ESPOJBT1FTXjnyx2XqQg3k72N2d69k/yRUojU8QpCOUg5Gw6riecTTh8JAJmaI8O3ymL+Ua8PXX2q2wp+2wLTq1ohnFr3n7XP2+dnRkfqp/KUjU30GWOPANf8YiKUzAzZgk/FTDKpXqpZ49as+e2PeIRSaGmQWoaskf58rmfs+Z8e6eqmtCKfr68M7XLtxzw6Xb7qJWm8eBvoc3AbIP2ypy1iR9v9erEv6J17vY7bTNLox4oSykz8d73N5uNtySiKYjaLC9B6xfA3h1sr5G3ctFXjU8FUUupL6rb8biKmR7Al1qBU9vb3fu7NlobQ2IOJ9SiYrU1oo4v3x7S/3pba2lPDqBiL8y2DyWScmarH8oXWsXTrgVVV3aFChBfk4TW/F+p9WXoV/92ho3QL//rDBt/ACzMAYg=
8hCgeAqHSjPhNc3X
